Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 89.70
+3.27 (3.78%)
At close: Dec 5, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 20.49 billion as of December 5, 2025. Its market cap has increased by 95.42% in one year.
Market Cap
20.49B
Enterprise Value
22.38B
Revenue
13.30B
Ranking
n/a
PE Ratio
22.94
Stock Price
89.70
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.49B, an increase of 186.83%. That is a compound annual growth rate of 26.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 20.49B | 31.70% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 125.16B |
| Abbott Laboratories (Pakistan) | 102.31B |
| The Searle Company | 61.31B |
| Highnoon Laboratories | 56.96B |
| AGP Limited | 52.38B |
| Shifa International Hospitals | 32.30B |
| Ferozsons Laboratories | 16.44B |
| Macter International | 15.46B |